Aurobindo Pharma Limited (NSE CODE: AUROPHARMA)
Buy around Rs.1209.00x60 shares with stoploss Rs.1136
Expected targets in February-2015
1st Target: Rs.1341.00
2nd Target: Rs.1407.00
3rd Target: Rs.1472.50
3rd Target: Rs.1472.50
------------------------------
Shareholding Pattern
Promoters 54.06%
Mutual Funds/UTI 6.35%
FII/Banks 29.85%
Others 9.73%
Mutual Funds/UTI 6.35%
FII/Banks 29.85%
Others 9.73%
------------------------------
Price Trend
YTD 6.52%
1 Week 2.70%
YTD 6.52%
1 Week 2.70%
1 Month 6.88%
1 Year 146.45%
3 Years 904.82%
1 Year 146.45%
3 Years 904.82%
-----------------------------
Company Profile
Company Profile
Aurobindo Pharma Limited (APL) is a global pharmaceutical company. The Company has product portfolio spread over product areas encompassing anti-retroviral, antibiotics, gastroenterologicals, anti-diabetics and anti-allergic. The Company develops, manufactures and markets active pharmaceutical ingredients (APIs) and finished dosage formulations. The generics portfolio offers 470 products/dossiers in major therapeutic areas of gastro-intestinal, cardiovascular/anti-diabetics, anti-retro virals, anti-allergics, anti-biotics, carbapenems, ophthalmics and oral contraceptives. In April 2014, the Company acquired certain commercial operations in Western Europe from Actavis plc.
web site : http://www.aurobindo.com/
No comments:
Post a Comment